Skip to content

Clinical trials

Phase 2 Glioblastoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20094
20101
20112
20123
20131
20152
20161
20171
20181
20191
20212
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated4
Recruiting3
Unknown status3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
European Organisation for Research and Treatment of Cancer - EORTC2
Hoffmann-La Roche2
AbbVie1
Apogenix GmbH1
EMD Serono1
Heinrich-Heine University, Duesseldorf1
Incyte Corporation1
Insel Gruppe AG, University Hospital Bern1
Isarna Therapeutics GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma26
Glioma7
Astrocytoma6
Brain Neoplasms5
Oligodendroglioma4
Central Nervous System Neoplasms3
Diffuse Intrinsic Pontine Glioma3
Recurrence2
Biliary Tract Neoplasms1
Camurati-Engelmann Syndrome1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.